#United States #Chicago #CME Group #Board of Directors #Derivatives Marketplace

CME Group Announces New Director Nominees for Upcoming Election

CME Group Inc., recognized globally as the leading derivatives marketplace, has revealed its list of director nominees ahead of the annual shareholder meeting scheduled for May 14, 2026. This announcement underlines the commitment of the organization to maintain a strong governance structure and ensure experienced leadership in guiding its strategic direction.

The current recommendation for election comprises a combination of seasoned executives and industry experts, aiming to enhance the board's effectiveness and representation. The slate includes Terrence A. Duffy, the Company’s Chairman and CEO, alongside other prominent figures such as Kathryn Benesh, a retired partner from Deloitte, and Timothy S. Bitsberger, who has a distinguished background with Freddie Mac and the U.S. Treasury.

Among the nominees are:

• - Terrence A. Duffy (67): Chairman and CEO, who aims to steer the group towards further operational excellence.
• - Kathryn Benesh (66): A certified public accountant and a retired partner at Deloitte, showcasing extensive financial oversight expertise.
• - Timothy S. Bitsberger (66): A retired Managing Director and Portfolio Specialist, with previous strategic roles at Freddie Mac and the U.S. Treasury, adding a wealth of financial services knowledge.
• - Charles P. Carey (72): Former Vice Chairman of CME Group and currently serving as Lead Director, reflecting continuity and experience within the Board.
• - Bryan T. Durkin (65): A former president of CME Group, bringing strong leadership insights.
• - Harold Ford Jr. (55): Regional President at PNC Financial Services Group and a former member of Congress, providing invaluable public policy knowledge to the Board.
• - Martin J. Gepsman (73): An independent broker and trader, bringing perspective from the trading floor.
• - Daniel G. Kaye (71): A retired partner of Ernst & Young LLP, adding significant accounting experience.
• - Phyllis M. Lockett (60): Founder and Senior Advisor of LEAP Innovations with a focus on technology and education, enriching the board with innovative insights.
• - Deborah J. Lucas (67): A Sloan Professor of Finance at MIT and director at the MIT Golub Center for Finance and Policy, reinforcing the Board's analytical framework.
• - Rahael Seifu (44): Currently overseeing legal matters at Google LLC, reflecting a robust understanding of corporate governance.
• - William R. Shepard (79): President and founder of Shepard International, Inc., bringing entrepreneurial experience to the team.
• - Howard J. Siegel (69): An independent trader whose expertise in market dynamics is a valuable asset.
• - Dennis A. Suskind (83): A retired partner at Goldman Sachs, with vast experience in investment banking.

Additionally, the CME Group's Nominating and Governance Committee has identified more nominees specifically for the Class B shareholders, illustrating a comprehensive approach to governance.

• - For Class B-1 shareholders, three roles will be filled by candidates like William W. Hobert, founder of WH Trading LLC, and Robert J. Tierney Jr., managing member and owner of Kore Trading LLC.
• - Class B-2 shareholders will nominate Patrick W. Maloney, an independent floor broker.
• - Lastly, Elizabeth A. Cook, will be nominated by Class B-3 shareholders as an independent broker and trader.

The CME Group stands pivotal in the derivatives marketplace, offering a variety of products that allow participants to trade in futures, options, and several other financial instruments globally. With a presence in diverse asset classes – including interest rates, equity indexes, and even cryptocurrencies – CME Group’s initiatives greatly influence global trading practices. The company continues to drive innovation and efficiency in risk management processes, allowing market participants to seize industry opportunities effectively.

Annual meetings such as this one help in reinforcing corporate governance and ensuring that shareholders have a voice in the direction of leadership. The slate of nominees reflects a mix of experience, governance expertise, and trades that align with CME Group's strategic focus.

For more information about the CME Group and the upcoming nominees, visit their official website or consult their Investor Relations resources. The continued success of CME Group in managing risk and providing a diverse range of trading options depends heavily on strong governance and experienced leadership, which this slate aims to provide.